Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the small intestine.
Biomarker and diagnostic research for small intestine neuroendocrine tumor, well differentiated, low or intermediate grade has been reported in the published literature.
No clinical trials have been registered for small intestine neuroendocrine tumor, well differentiated, low or intermediate grade.
218 publications have been identified in PubMed for small intestine neuroendocrine tumor, well differentiated, low or intermediate grade. Kisho has analyzed 116 by research type. Research spans Review / Meta-Analysis (34%), Diagnostic / Biomarker (17%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 40 |
Data assembled from 2 of 12 sources · Last updated Sep 21, 2026, 9:20 AM UTC
Testing and diagnosis research | 20 | 17% |
Disease patterns and progression | 20 | 17% |
Clinical study results | 19 | 16% |
Laboratory research | 15 | 13% |
Patient case studies | 1 | 1% |
New treatment approaches | 1 | 1% |
Sheng YH (2026). [PMID: 41693974](https://pubmed.ncbi.nlm.nih.gov/41693974/). *World J Gastroenterol*. [Review / Meta-Analysis]
Hou G (2026). [PMID: 41134321](https://pubmed.ncbi.nlm.nih.gov/41134321/). *Eur J Nucl Med Mol Imaging*. [Diagnostic / Biomarker]
Sountoulidis A (2026). [PMID: 41851103](https://pubmed.ncbi.nlm.nih.gov/41851103/). *Nat Commun*. [Basic Science / Preclinical]
Cella L (2026). [PMID: 42041162](https://pubmed.ncbi.nlm.nih.gov/42041162/). *Future Oncol*. [Review / Meta-Analysis]
Hercent A (2026). [PMID: 41416936](https://pubmed.ncbi.nlm.nih.gov/41416936/). *J Pathol*. [Basic Science / Preclinical]
van den Heerik ASVM (2026). [PMID: 41449145](https://pubmed.ncbi.nlm.nih.gov/41449145/). *Lancet Oncol*. [Clinical Trial Publication]
Boualoy T (2026). [PMID: 30725765](https://pubmed.ncbi.nlm.nih.gov/30725765/). *Unknown Journal*. [Epidemiology / Natural History]
Kennecke H (2026). [PMID: 41562331](https://pubmed.ncbi.nlm.nih.gov/41562331/). *Endocr Relat Cancer*. [Review / Meta-Analysis]
Scuderi S (2026). [PMID: 41002165](https://pubmed.ncbi.nlm.nih.gov/41002165/). *J Natl Cancer Inst*. [Diagnostic / Biomarker]
Cameron MA (2026). [PMID: 42106179](https://pubmed.ncbi.nlm.nih.gov/42106179/). *Handb Clin Neurol*. [Review / Meta-Analysis]